Legal & General Group »

Aerovate Therapeutics shares owned by Legal & General Group

Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by Legal & General Group from 13F filings

Historical chart of Legal & General Group investment in Aerovate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aerovate Therapeutics held by Legal & General Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aerovate Therapeutics by Legal & General Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $38k 1.7k 22.63
2023-09-30 $104k 7.7k 13.57
2023-06-30 $99k 5.8k 17.15
2023-03-31 $69k 3.4k 20.17
2022-12-31 $95k 3.2k 29.30
2022-09-30 $13k 774 16.80
2022-06-30 $6.0k 414 14.49
2022-03-31 $25k 1.3k 18.64
2021-12-31 $11k 941 11.69
2021-09-30 $20k 941 21.25